Skip to main content

Chemical Entities of Biological Interest Ontology (CHEBI)

Search from vocabulary

  • Help
align
annotate
download

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > fatty acid derivative > icosanoid > prostanoid > prostaglandin > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteropolycyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > heteropolycyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heterobicyclic compound > organic heterobicyclic compound > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > bicyclic compound > heterobicyclic compound > organic heterobicyclic compound > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > cyclopentafuran > prostaglandins I > 15-dehydro-prostaglandin I2

Preferred term

15-dehydro-prostaglandin I2  

Broader concept

Synonym(s)

  • (5Z,13E)-6,9alpha-epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoic acid

Belongs to group

URI

http://data.loterre.fr/ark:/67375/KFP-VDDC4LJZ-2

Download this concept:

RDF/XML TURTLE JSON-LD